Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Quadrivalent Influenza Vaccine in Healthy People Aged 3-60
NCT02806804Phase 3Unknown
- Sponsor
- Beijing Chaoyang District Center for Disease Control and Prevention
- Start
- May 2016
- Primary completion
- Jun 2016
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of quadrivalent influenza virus vaccine in influenza, sponsored by Beijing Chaoyang District Center for Disease Control and Prevention. Status: unknown.
02
Drugs
quadrivalent influenza virus vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02806804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02806804.